interferon alfa-2b follow-on biologic (Amoytop)

N/A

Report date: 2026/01/06 11:34:02

Base Information

Drug Nameinterferon alfa-2b follow-on biologic (Amoytop)
Drug Alias Nameinterferon alfa-2b
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Biosimilar
Mechanisms of ActionInterferon alpha 2 ligand
TargetsInterferon alpha-2
Therapy Area/IndicationsMelanomaLymphoma, FollicularLeukemia, Hairy Cell +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesXiamen Amoytop Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Amoytop Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsMelanomaLymphoma, FollicularLeukemia, Hairy Cell +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A